Editas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Editas Medicine's Third Quarter Conference Call. All participants are now in listen-only mode.

Related Keywords

Baisong Mei ,Gilmore Oneill ,Samantha Semenkow ,Caren Deardorf ,Cristi Barnett ,Linda Berkley ,Linda Burkly ,Joon Lee ,Erick Lucera ,Brian Cheng ,Harvard University ,Corporate Communications ,European Hematology Association Congress ,Broad Institute Cas ,Nasdaq ,Editas Medicine Inc ,Editas Medicine ,Call Transcript November ,Third Quarter Conference ,Investor Relations ,Safe Harbor ,Private Securities Litigation Reform Act ,Risk Factors ,Annual Report ,Chief Medical Officer ,Chief Financial Officer ,Chief Scientific Officer ,Chief Commercial ,Chief Scientific ,Regenerative Medicine Advanced Therapy ,Fast Track ,Vor Bio ,Broad Institute ,Chief Medical ,Chief Financial ,Profitable Agricultural Business Ideas ,Young Entrepreneurs ,Racist States ,